Ticker INDVListed on Nasdaq

Supernus, Inc.

Pharmaceutical PreparationsCIK 0001625297Rockville, MarylandFilings at SEC EDGAR

At a glance

Most recent filing on August 27, 2026 — an open-market purchase by Anderson Woodrow D on Aug 27, 2026.

We hold 3 Form 4 lines, going back to July 13, 2026.

All 3 shown

CEO pay

What the company reported for its principal executive officer, usually the CEO, in the pay-versus-performance table of its proxy statement. The total counts shares and options at their value on the day they were granted. Actually paid counts them at the change in their value during the year, so it can be far higher or lower than the total, and negative. A dash means the company reported no amount.

Joe Ciaffoni, fiscal year ended Dec 31, 2025: total $18,501,214, actually paid $63,340,102. First reported Mar 27, 2026.

Mark Crossley, fiscal year ended Dec 31, 2025: total $3,185,591, actually paid $19,299,866. First reported Mar 27, 2026.

Earlier fiscal years are part of the subscription.